Neptune, the Next Pluto?-Durvalumab and Tremelimumab Face Challenges in Entering the NSCLC Space. Ahn JY, Nagasaka M. J Thorac Oncol 2023;18:29-30.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Ahn JY, Nagasaka M. Neptune, the Next Pluto?-Durvalumab and Tremelimumab Face Challenges in Entering the NSCLC Space. J Thorac Oncol 2023;18:29-30.
PMID: 36543434